| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoplastic Left Heart Syndrome | 47 | 2023 | 79 | 8.280 |
Why?
|
| Heart Defects, Congenital | 55 | 2025 | 368 | 7.370 |
Why?
|
| Norwood Procedures | 27 | 2023 | 41 | 6.550 |
Why?
|
| Cardiac Surgical Procedures | 55 | 2025 | 508 | 5.170 |
Why?
|
| Palliative Care | 26 | 2022 | 290 | 3.090 |
Why?
|
| Heart Ventricles | 20 | 2021 | 664 | 2.640 |
Why?
|
| Monitoring, Physiologic | 15 | 2020 | 263 | 2.550 |
Why?
|
| Infant, Newborn | 75 | 2025 | 2529 | 2.140 |
Why?
|
| Oximetry | 17 | 2022 | 94 | 2.000 |
Why?
|
| Spectroscopy, Near-Infrared | 12 | 2016 | 42 | 1.920 |
Why?
|
| Oxygen | 18 | 2022 | 802 | 1.900 |
Why?
|
| Home Care Services, Hospital-Based | 5 | 2014 | 10 | 1.720 |
Why?
|
| Infant | 63 | 2025 | 3328 | 1.670 |
Why?
|
| Child Development | 12 | 2020 | 179 | 1.560 |
Why?
|
| Postoperative Complications | 27 | 2025 | 2681 | 1.350 |
Why?
|
| Blalock-Taussig Procedure | 9 | 2021 | 12 | 1.280 |
Why?
|
| Heart Bypass, Right | 7 | 2015 | 12 | 1.260 |
Why?
|
| Monitoring, Ambulatory | 4 | 2014 | 32 | 1.220 |
Why?
|
| Risk Factors | 49 | 2025 | 6232 | 1.210 |
Why?
|
| Heart-Assist Devices | 8 | 2021 | 916 | 1.140 |
Why?
|
| Fontan Procedure | 11 | 2019 | 58 | 1.120 |
Why?
|
| Child | 47 | 2025 | 7681 | 1.060 |
Why?
|
| Pulmonary Artery | 14 | 2021 | 342 | 1.020 |
Why?
|
| Developmental Disabilities | 7 | 2020 | 211 | 1.000 |
Why?
|
| Hemodynamics | 15 | 2021 | 747 | 0.980 |
Why?
|
| Critical Care | 14 | 2022 | 483 | 0.940 |
Why?
|
| Registries | 12 | 2025 | 1122 | 0.910 |
Why?
|
| Preoperative Care | 5 | 2014 | 418 | 0.860 |
Why?
|
| Humans | 145 | 2025 | 98076 | 0.860 |
Why?
|
| Retrospective Studies | 45 | 2025 | 10972 | 0.840 |
Why?
|
| Treatment Outcome | 47 | 2022 | 9711 | 0.820 |
Why?
|
| Child, Preschool | 33 | 2025 | 4001 | 0.820 |
Why?
|
| Respiration, Artificial | 7 | 2019 | 462 | 0.770 |
Why?
|
| Hospital Mortality | 16 | 2025 | 541 | 0.770 |
Why?
|
| Nutritional Support | 2 | 2014 | 20 | 0.760 |
Why?
|
| Gastrostomy | 3 | 2018 | 67 | 0.760 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2022 | 55 | 0.750 |
Why?
|
| Time Factors | 32 | 2025 | 5567 | 0.720 |
Why?
|
| Postoperative Care | 6 | 2019 | 236 | 0.690 |
Why?
|
| Critical Illness | 3 | 2016 | 436 | 0.640 |
Why?
|
| Heart Transplantation | 7 | 2020 | 873 | 0.640 |
Why?
|
| Nervous System | 4 | 2019 | 92 | 0.630 |
Why?
|
| Weight Gain | 3 | 2020 | 134 | 0.630 |
Why?
|
| Abnormalities, Multiple | 2 | 2019 | 235 | 0.620 |
Why?
|
| Turner Syndrome | 1 | 2019 | 27 | 0.610 |
Why?
|
| Health Resources | 3 | 2017 | 80 | 0.600 |
Why?
|
| Male | 74 | 2025 | 47075 | 0.590 |
Why?
|
| Life Support Care | 1 | 2019 | 58 | 0.580 |
Why?
|
| Female | 72 | 2025 | 51535 | 0.570 |
Why?
|
| Consensus | 2 | 2019 | 315 | 0.560 |
Why?
|
| Continuity of Patient Care | 3 | 2012 | 179 | 0.560 |
Why?
|
| Intensive Care Units, Pediatric | 8 | 2019 | 123 | 0.550 |
Why?
|
| Attitude to Health | 1 | 2019 | 217 | 0.550 |
Why?
|
| Cerebrovascular Circulation | 6 | 2021 | 239 | 0.540 |
Why?
|
| Enteral Nutrition | 4 | 2020 | 104 | 0.540 |
Why?
|
| Family | 1 | 2019 | 327 | 0.530 |
Why?
|
| Follow-Up Studies | 23 | 2021 | 4025 | 0.530 |
Why?
|
| Patient Care Team | 2 | 2020 | 320 | 0.520 |
Why?
|
| Pulmonary Circulation | 6 | 2022 | 92 | 0.510 |
Why?
|
| Cardiopulmonary Bypass | 7 | 2020 | 161 | 0.510 |
Why?
|
| Child Behavior | 2 | 2019 | 50 | 0.510 |
Why?
|
| Patient Readmission | 2 | 2021 | 424 | 0.490 |
Why?
|
| Wisconsin | 9 | 2019 | 45 | 0.490 |
Why?
|
| Incidence | 11 | 2025 | 1779 | 0.480 |
Why?
|
| Length of Stay | 15 | 2022 | 878 | 0.460 |
Why?
|
| Vasodilator Agents | 2 | 2014 | 134 | 0.460 |
Why?
|
| Alprostadil | 2 | 2014 | 25 | 0.460 |
Why?
|
| Heart Failure | 5 | 2021 | 1491 | 0.450 |
Why?
|
| Risk Assessment | 17 | 2025 | 2585 | 0.450 |
Why?
|
| Quality Improvement | 8 | 2023 | 520 | 0.450 |
Why?
|
| Health Care Costs | 1 | 2017 | 257 | 0.440 |
Why?
|
| Quality Assurance, Health Care | 3 | 2017 | 228 | 0.440 |
Why?
|
| Cardiac Catheterization | 7 | 2019 | 307 | 0.440 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 80 | 0.420 |
Why?
|
| Cardiotonic Agents | 1 | 2014 | 92 | 0.410 |
Why?
|
| Chronic Disease | 1 | 2017 | 984 | 0.400 |
Why?
|
| Cardiology | 3 | 2023 | 124 | 0.400 |
Why?
|
| Postoperative Period | 9 | 2021 | 321 | 0.390 |
Why?
|
| Nutritional Status | 2 | 2023 | 83 | 0.390 |
Why?
|
| Prospective Studies | 20 | 2022 | 4823 | 0.380 |
Why?
|
| Aortic Valve Stenosis | 1 | 2014 | 156 | 0.380 |
Why?
|
| Cognition | 4 | 2019 | 672 | 0.370 |
Why?
|
| Intracranial Hemorrhages | 1 | 2013 | 138 | 0.370 |
Why?
|
| Reoperation | 6 | 2025 | 727 | 0.370 |
Why?
|
| Pediatrics | 4 | 2022 | 421 | 0.370 |
Why?
|
| Failure to Thrive | 1 | 2012 | 17 | 0.360 |
Why?
|
| Aprotinin | 3 | 2009 | 24 | 0.360 |
Why?
|
| Cause of Death | 3 | 2019 | 278 | 0.360 |
Why?
|
| Transposition of Great Vessels | 4 | 2017 | 24 | 0.360 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2013 | 59 | 0.360 |
Why?
|
| Motor Activity | 2 | 2019 | 328 | 0.360 |
Why?
|
| Patient Discharge | 5 | 2021 | 381 | 0.350 |
Why?
|
| Societies, Medical | 3 | 2016 | 682 | 0.350 |
Why?
|
| Databases, Factual | 5 | 2018 | 1094 | 0.350 |
Why?
|
| United States | 20 | 2025 | 8196 | 0.350 |
Why?
|
| Drug Hypersensitivity | 2 | 2009 | 38 | 0.340 |
Why?
|
| Attention | 2 | 2013 | 435 | 0.340 |
Why?
|
| Stroke | 1 | 2021 | 1154 | 0.340 |
Why?
|
| Hemostatics | 2 | 2009 | 64 | 0.330 |
Why?
|
| Vascular Resistance | 6 | 2019 | 98 | 0.310 |
Why?
|
| Heart Diseases | 4 | 2019 | 268 | 0.310 |
Why?
|
| Thoracic Surgery | 2 | 2021 | 72 | 0.310 |
Why?
|
| Intraoperative Care | 2 | 2009 | 90 | 0.310 |
Why?
|
| Extracorporeal Membrane Oxygenation | 8 | 2019 | 238 | 0.300 |
Why?
|
| Survival Rate | 10 | 2019 | 2041 | 0.300 |
Why?
|
| Intraoperative Complications | 3 | 2017 | 194 | 0.300 |
Why?
|
| Perioperative Care | 5 | 2015 | 198 | 0.280 |
Why?
|
| Ventilator Weaning | 1 | 2008 | 45 | 0.280 |
Why?
|
| Adolescent | 16 | 2021 | 10079 | 0.270 |
Why?
|
| Cardiac Output | 3 | 2019 | 142 | 0.270 |
Why?
|
| Hemoglobins | 2 | 2022 | 198 | 0.260 |
Why?
|
| Gastrointestinal Diseases | 1 | 2008 | 155 | 0.250 |
Why?
|
| Multivariate Analysis | 7 | 2015 | 1009 | 0.250 |
Why?
|
| Oxygen Consumption | 3 | 2022 | 239 | 0.250 |
Why?
|
| Intensive Care Units | 5 | 2019 | 520 | 0.250 |
Why?
|
| Infant Mortality | 4 | 2021 | 68 | 0.240 |
Why?
|
| Aorta | 2 | 2006 | 275 | 0.230 |
Why?
|
| Gestational Age | 4 | 2020 | 340 | 0.230 |
Why?
|
| Respiratory Insufficiency | 1 | 2008 | 211 | 0.230 |
Why?
|
| Anticoagulants | 4 | 2015 | 486 | 0.230 |
Why?
|
| Cooperative Behavior | 2 | 2019 | 199 | 0.230 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2018 | 903 | 0.230 |
Why?
|
| Hospitals, Pediatric | 4 | 2021 | 128 | 0.230 |
Why?
|
| Morbidity | 6 | 2021 | 162 | 0.220 |
Why?
|
| Cardiac Output, Low | 3 | 2020 | 12 | 0.220 |
Why?
|
| Age Factors | 8 | 2021 | 1962 | 0.220 |
Why?
|
| Body Weight | 3 | 2013 | 455 | 0.220 |
Why?
|
| Brain Ischemia | 2 | 2006 | 416 | 0.220 |
Why?
|
| Trachea | 2 | 2017 | 249 | 0.210 |
Why?
|
| Home Nursing | 2 | 2020 | 17 | 0.210 |
Why?
|
| Logistic Models | 7 | 2019 | 1275 | 0.200 |
Why?
|
| Kidney Diseases | 2 | 2021 | 314 | 0.200 |
Why?
|
| Chi-Square Distribution | 3 | 2013 | 360 | 0.190 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2012 | 98 | 0.190 |
Why?
|
| Malnutrition | 1 | 2023 | 39 | 0.190 |
Why?
|
| Neuropsychological Tests | 3 | 2014 | 566 | 0.180 |
Why?
|
| Physicians | 2 | 2022 | 685 | 0.180 |
Why?
|
| Methadone | 1 | 2022 | 54 | 0.170 |
Why?
|
| Brain Chemistry | 1 | 2021 | 110 | 0.170 |
Why?
|
| Vasomotor System | 1 | 2001 | 13 | 0.170 |
Why?
|
| Linear Models | 2 | 2013 | 424 | 0.170 |
Why?
|
| Anastomosis, Surgical | 5 | 2017 | 289 | 0.170 |
Why?
|
| Prognosis | 6 | 2019 | 4116 | 0.170 |
Why?
|
| Morphine | 1 | 2022 | 127 | 0.170 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 540 | 0.160 |
Why?
|
| Hospitalization | 4 | 2022 | 991 | 0.160 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2017 | 66 | 0.160 |
Why?
|
| Down Syndrome | 1 | 2020 | 54 | 0.160 |
Why?
|
| Regression Analysis | 4 | 2019 | 578 | 0.160 |
Why?
|
| North America | 4 | 2013 | 210 | 0.150 |
Why?
|
| Models, Theoretical | 1 | 2022 | 508 | 0.150 |
Why?
|
| Animals, Newborn | 1 | 2001 | 524 | 0.150 |
Why?
|
| Bioethical Issues | 1 | 2019 | 39 | 0.150 |
Why?
|
| Health Information Systems | 1 | 2019 | 7 | 0.150 |
Why?
|
| Vasopressins | 1 | 2019 | 49 | 0.150 |
Why?
|
| Cohort Studies | 8 | 2019 | 3212 | 0.150 |
Why?
|
| Chest Tubes | 1 | 2019 | 21 | 0.150 |
Why?
|
| Risk Adjustment | 1 | 2019 | 43 | 0.140 |
Why?
|
| Birth Weight | 1 | 2019 | 150 | 0.140 |
Why?
|
| Probability | 4 | 2009 | 356 | 0.140 |
Why?
|
| Patient Care | 1 | 2019 | 99 | 0.140 |
Why?
|
| Heart | 1 | 2021 | 527 | 0.140 |
Why?
|
| Anaerobic Threshold | 3 | 2010 | 4 | 0.140 |
Why?
|
| Atrioventricular Block | 1 | 2018 | 33 | 0.140 |
Why?
|
| Ventricular Function | 3 | 2013 | 41 | 0.140 |
Why?
|
| Renal Dialysis | 1 | 2021 | 357 | 0.140 |
Why?
|
| Drainage | 1 | 2019 | 176 | 0.140 |
Why?
|
| Device Removal | 1 | 2019 | 170 | 0.130 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 1782 | 0.130 |
Why?
|
| Quality of Health Care | 2 | 2019 | 391 | 0.130 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 194 | 0.130 |
Why?
|
| Bronchial Diseases | 1 | 2017 | 12 | 0.130 |
Why?
|
| Multicenter Studies as Topic | 3 | 2013 | 200 | 0.130 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 445 | 0.130 |
Why?
|
| Tracheal Stenosis | 1 | 2017 | 27 | 0.120 |
Why?
|
| Hematocrit | 1 | 2016 | 68 | 0.120 |
Why?
|
| Comorbidity | 2 | 2019 | 1032 | 0.120 |
Why?
|
| Heterotaxy Syndrome | 1 | 2016 | 5 | 0.120 |
Why?
|
| Vascular System Injuries | 1 | 2017 | 47 | 0.120 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 211 | 0.120 |
Why?
|
| Recovery of Function | 2 | 2018 | 370 | 0.120 |
Why?
|
| Coronary Care Units | 1 | 2016 | 5 | 0.120 |
Why?
|
| Antithrombin III | 1 | 2015 | 9 | 0.120 |
Why?
|
| Survival Analysis | 7 | 2012 | 1527 | 0.120 |
Why?
|
| Bronchi | 1 | 2017 | 229 | 0.120 |
Why?
|
| Microsurgery | 1 | 2017 | 120 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2019 | 418 | 0.110 |
Why?
|
| Blood Coagulation | 1 | 2015 | 90 | 0.110 |
Why?
|
| Bacteremia | 1 | 2016 | 111 | 0.110 |
Why?
|
| Spleen | 1 | 2016 | 375 | 0.110 |
Why?
|
| Congresses as Topic | 1 | 2016 | 123 | 0.110 |
Why?
|
| Postoperative Hemorrhage | 1 | 2015 | 55 | 0.110 |
Why?
|
| Fetal Growth Retardation | 1 | 2015 | 73 | 0.110 |
Why?
|
| Treatment Failure | 3 | 2014 | 300 | 0.110 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 100 | 0.110 |
Why?
|
| Balloon Valvuloplasty | 1 | 2014 | 9 | 0.110 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 164 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2016 | 184 | 0.110 |
Why?
|
| Apolipoprotein E2 | 1 | 2014 | 3 | 0.110 |
Why?
|
| Odds Ratio | 2 | 2016 | 726 | 0.110 |
Why?
|
| Proportional Hazards Models | 5 | 2018 | 922 | 0.110 |
Why?
|
| Tracheobronchomalacia | 1 | 2014 | 11 | 0.110 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2014 | 6 | 0.100 |
Why?
|
| Vocal Cord Paralysis | 1 | 2014 | 27 | 0.100 |
Why?
|
| Enalapril | 2 | 2011 | 10 | 0.100 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2014 | 45 | 0.100 |
Why?
|
| Organ Dysfunction Scores | 1 | 2014 | 36 | 0.100 |
Why?
|
| Phenoxybenzamine | 3 | 2004 | 15 | 0.100 |
Why?
|
| Energy Intake | 1 | 2014 | 99 | 0.100 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2013 | 21 | 0.100 |
Why?
|
| Databases as Topic | 2 | 2010 | 96 | 0.100 |
Why?
|
| Child Language | 1 | 2013 | 6 | 0.100 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2012 | 5 | 0.100 |
Why?
|
| Vena Cava, Superior | 4 | 2007 | 54 | 0.100 |
Why?
|
| Hypoxia | 4 | 2012 | 699 | 0.090 |
Why?
|
| Young Adult | 4 | 2017 | 7507 | 0.090 |
Why?
|
| Nonlinear Dynamics | 1 | 2013 | 66 | 0.090 |
Why?
|
| Growth | 1 | 2012 | 42 | 0.090 |
Why?
|
| Double-Blind Method | 5 | 2019 | 1782 | 0.090 |
Why?
|
| Stress, Psychological | 2 | 2013 | 383 | 0.090 |
Why?
|
| Heart Arrest | 1 | 2016 | 321 | 0.090 |
Why?
|
| Pituitary-Adrenal System | 1 | 2012 | 69 | 0.090 |
Why?
|
| Kidney | 2 | 2010 | 1123 | 0.090 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2012 | 83 | 0.090 |
Why?
|
| Echocardiography | 3 | 2021 | 783 | 0.090 |
Why?
|
| Heparin | 2 | 2015 | 182 | 0.090 |
Why?
|
| Skin Tests | 2 | 2009 | 53 | 0.090 |
Why?
|
| Cyanosis | 2 | 2012 | 9 | 0.090 |
Why?
|
| Saliva | 1 | 2012 | 134 | 0.090 |
Why?
|
| Brain | 2 | 2014 | 2430 | 0.090 |
Why?
|
| Prenatal Diagnosis | 1 | 2012 | 107 | 0.080 |
Why?
|
| Growth Disorders | 1 | 2011 | 64 | 0.080 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 51 | 0.080 |
Why?
|
| Disease-Free Survival | 4 | 2018 | 1193 | 0.080 |
Why?
|
| Evidence-Based Practice | 1 | 2011 | 54 | 0.080 |
Why?
|
| Feasibility Studies | 4 | 2017 | 801 | 0.080 |
Why?
|
| Adult | 8 | 2021 | 29538 | 0.080 |
Why?
|
| Hydrocortisone | 1 | 2012 | 305 | 0.080 |
Why?
|
| Pilot Projects | 4 | 2019 | 977 | 0.080 |
Why?
|
| Algorithms | 1 | 2019 | 2002 | 0.080 |
Why?
|
| Renal Circulation | 1 | 2010 | 30 | 0.080 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2011 | 91 | 0.080 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2010 | 43 | 0.080 |
Why?
|
| Myocarditis | 1 | 2011 | 60 | 0.080 |
Why?
|
| Documentation | 1 | 2011 | 111 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2012 | 1012 | 0.080 |
Why?
|
| Caregivers | 2 | 2020 | 200 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 295 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 3 | 2013 | 1109 | 0.080 |
Why?
|
| Parents | 1 | 2013 | 321 | 0.080 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2009 | 25 | 0.080 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 508 | 0.080 |
Why?
|
| Exercise Tolerance | 1 | 2010 | 67 | 0.080 |
Why?
|
| Epidemiologic Methods | 1 | 2009 | 60 | 0.080 |
Why?
|
| Texas | 2 | 2020 | 136 | 0.070 |
Why?
|
| Drug Eruptions | 1 | 2009 | 35 | 0.070 |
Why?
|
| Diffusion of Innovation | 1 | 2009 | 81 | 0.070 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2009 | 19 | 0.070 |
Why?
|
| Oxyhemoglobins | 1 | 2009 | 31 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 1945 | 0.070 |
Why?
|
| Venous Thromboembolism | 1 | 2011 | 177 | 0.070 |
Why?
|
| Mitral Valve Stenosis | 1 | 2008 | 27 | 0.070 |
Why?
|
| Patient Selection | 1 | 2012 | 726 | 0.070 |
Why?
|
| Exercise Test | 1 | 2009 | 158 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2009 | 839 | 0.070 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2007 | 6 | 0.070 |
Why?
|
| Ventricular Dysfunction | 1 | 2007 | 24 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2019 | 2013 | 0.070 |
Why?
|
| Multiple Organ Failure | 2 | 2023 | 64 | 0.060 |
Why?
|
| Reference Values | 2 | 2010 | 608 | 0.060 |
Why?
|
| Heart Rupture | 1 | 2007 | 7 | 0.060 |
Why?
|
| Papillary Muscles | 1 | 2007 | 18 | 0.060 |
Why?
|
| Adaptation, Psychological | 1 | 2008 | 190 | 0.060 |
Why?
|
| Stroke Volume | 3 | 2021 | 464 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2007 | 282 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2006 | 19 | 0.060 |
Why?
|
| Blood Platelets | 1 | 2007 | 153 | 0.060 |
Why?
|
| Aortic Valve | 1 | 2008 | 258 | 0.060 |
Why?
|
| Infant, Premature | 2 | 2020 | 305 | 0.060 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2007 | 108 | 0.060 |
Why?
|
| Rabies virus | 1 | 2005 | 6 | 0.060 |
Why?
|
| Rabies | 1 | 2005 | 6 | 0.060 |
Why?
|
| Antibodies | 1 | 2007 | 348 | 0.060 |
Why?
|
| Ketamine | 1 | 2005 | 31 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2007 | 284 | 0.060 |
Why?
|
| Coma | 1 | 2005 | 46 | 0.060 |
Why?
|
| Anesthetics | 1 | 2005 | 51 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2783 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2005 | 52 | 0.050 |
Why?
|
| Ligation | 2 | 2014 | 55 | 0.050 |
Why?
|
| Biomarkers | 1 | 2010 | 2020 | 0.050 |
Why?
|
| Risk Management | 1 | 2003 | 45 | 0.050 |
Why?
|
| Mycoplasma hominis | 1 | 2002 | 1 | 0.050 |
Why?
|
| Ureaplasma | 1 | 2002 | 3 | 0.050 |
Why?
|
| Ureaplasma Infections | 1 | 2002 | 4 | 0.050 |
Why?
|
| Brain Abscess | 1 | 2002 | 8 | 0.050 |
Why?
|
| Program Development | 1 | 2003 | 141 | 0.050 |
Why?
|
| Mycoplasma Infections | 1 | 2002 | 9 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2014 | 308 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2005 | 369 | 0.050 |
Why?
|
| Opioid-Related Disorders | 1 | 2006 | 256 | 0.040 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2002 | 94 | 0.040 |
Why?
|
| Blood Volume | 1 | 2021 | 41 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2006 | 789 | 0.040 |
Why?
|
| Arteries | 2 | 2017 | 171 | 0.040 |
Why?
|
| Hypoxia, Brain | 1 | 2021 | 41 | 0.040 |
Why?
|
| Disease Progression | 1 | 2006 | 1610 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 66 | 0.040 |
Why?
|
| Regional Blood Flow | 2 | 2013 | 194 | 0.040 |
Why?
|
| Alkalosis | 1 | 2000 | 10 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 2 | 2013 | 166 | 0.040 |
Why?
|
| Acidosis | 1 | 2000 | 55 | 0.040 |
Why?
|
| Airway Extubation | 1 | 2020 | 21 | 0.040 |
Why?
|
| Vasodilation | 1 | 2000 | 91 | 0.040 |
Why?
|
| Ventricular Function, Right | 2 | 2014 | 146 | 0.040 |
Why?
|
| Transitional Care | 1 | 2020 | 26 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 373 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 2 | 2001 | 382 | 0.040 |
Why?
|
| American Heart Association | 1 | 2020 | 117 | 0.040 |
Why?
|
| Fetus | 1 | 2001 | 237 | 0.040 |
Why?
|
| Antidiuretic Agents | 1 | 2019 | 3 | 0.040 |
Why?
|
| Checklist | 1 | 2020 | 78 | 0.040 |
Why?
|
| Language Development | 1 | 2019 | 22 | 0.040 |
Why?
|
| Quality of Life | 1 | 2008 | 1895 | 0.040 |
Why?
|
| Reflex, Pupillary | 1 | 2019 | 7 | 0.040 |
Why?
|
| Diagnosis-Related Groups | 1 | 2019 | 21 | 0.040 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1999 | 30 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 336 | 0.040 |
Why?
|
| Thinness | 1 | 2019 | 48 | 0.040 |
Why?
|
| Cost Savings | 1 | 2019 | 68 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 412 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2019 | 117 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2015 | 1995 | 0.030 |
Why?
|
| Myocardium | 1 | 2021 | 578 | 0.030 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2018 | 116 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 155 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 449 | 0.030 |
Why?
|
| Benchmarking | 1 | 2017 | 86 | 0.030 |
Why?
|
| Curriculum | 1 | 2022 | 633 | 0.030 |
Why?
|
| Communication | 1 | 2020 | 455 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2018 | 387 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 296 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 523 | 0.030 |
Why?
|
| Certification | 1 | 2016 | 67 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 2016 | 50 | 0.030 |
Why?
|
| Feeding Methods | 1 | 2015 | 2 | 0.030 |
Why?
|
| Blood Coagulation Tests | 1 | 2015 | 31 | 0.030 |
Why?
|
| Aortic Coarctation | 1 | 2015 | 31 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1950 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2017 | 182 | 0.030 |
Why?
|
| Seizures | 1 | 2018 | 318 | 0.030 |
Why?
|
| Thrombosis | 1 | 2018 | 318 | 0.030 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2015 | 86 | 0.030 |
Why?
|
| Dysphonia | 1 | 2014 | 7 | 0.030 |
Why?
|
| Work of Breathing | 1 | 2014 | 7 | 0.030 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 1 | 2014 | 20 | 0.030 |
Why?
|
| Patient Safety | 1 | 2017 | 235 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 2014 | 40 | 0.030 |
Why?
|
| Hospital Charges | 1 | 2014 | 31 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 70 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2014 | 66 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 993 | 0.030 |
Why?
|
| Polytetrafluoroethylene | 1 | 2013 | 72 | 0.020 |
Why?
|
| Lung | 1 | 2000 | 1407 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2014 | 164 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2016 | 259 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2014 | 154 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2013 | 97 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 2014 | 126 | 0.020 |
Why?
|
| Data Collection | 1 | 2014 | 376 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2012 | 74 | 0.020 |
Why?
|
| Canada | 1 | 2012 | 211 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 1384 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2012 | 76 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2013 | 255 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2012 | 137 | 0.020 |
Why?
|
| Body Surface Area | 1 | 2011 | 38 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2016 | 865 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2012 | 256 | 0.020 |
Why?
|
| Aldosterone | 1 | 2010 | 57 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2010 | 81 | 0.020 |
Why?
|
| Technology Transfer | 1 | 2009 | 5 | 0.020 |
Why?
|
| Organizational Innovation | 1 | 2009 | 42 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 349 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2010 | 299 | 0.020 |
Why?
|
| Shock, Cardiogenic | 1 | 2011 | 183 | 0.020 |
Why?
|
| Cardiac Care Facilities | 1 | 2008 | 2 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 440 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2010 | 267 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2008 | 75 | 0.020 |
Why?
|
| Child Welfare | 1 | 2008 | 44 | 0.020 |
Why?
|
| Platelet Factor 4 | 1 | 2007 | 10 | 0.020 |
Why?
|
| Animals | 3 | 2005 | 28894 | 0.020 |
Why?
|
| Leadership | 1 | 2009 | 159 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 2638 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 315 | 0.020 |
Why?
|
| Replantation | 1 | 2007 | 35 | 0.020 |
Why?
|
| Risk | 1 | 2008 | 660 | 0.020 |
Why?
|
| Psychometrics | 1 | 2008 | 356 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2007 | 194 | 0.010 |
Why?
|
| Dysarthria | 1 | 2005 | 5 | 0.010 |
Why?
|
| Athetosis | 1 | 2005 | 4 | 0.010 |
Why?
|
| Bites and Stings | 1 | 2005 | 9 | 0.010 |
Why?
|
| Amantadine | 1 | 2005 | 17 | 0.010 |
Why?
|
| Chorea | 1 | 2005 | 14 | 0.010 |
Why?
|
| Midazolam | 1 | 2005 | 48 | 0.010 |
Why?
|
| Ribavirin | 1 | 2005 | 37 | 0.010 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2005 | 25 | 0.010 |
Why?
|
| Indicator Dilution Techniques | 1 | 2005 | 6 | 0.010 |
Why?
|
| Motor Skills | 1 | 2005 | 80 | 0.010 |
Why?
|
| Calorimetry, Indirect | 1 | 2005 | 13 | 0.010 |
Why?
|
| Benzodiazepines | 1 | 2005 | 56 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 2555 | 0.010 |
Why?
|
| Reflex | 1 | 2005 | 82 | 0.010 |
Why?
|
| Shock | 1 | 2005 | 56 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2005 | 163 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2004 | 6 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2005 | 118 | 0.010 |
Why?
|
| Pregnancy | 1 | 2012 | 3244 | 0.010 |
Why?
|
| Oxygenators | 1 | 2004 | 3 | 0.010 |
Why?
|
| Chiroptera | 1 | 2005 | 59 | 0.010 |
Why?
|
| Cell Respiration | 1 | 2004 | 21 | 0.010 |
Why?
|
| Research Design | 1 | 2008 | 660 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2004 | 75 | 0.010 |
Why?
|
| Veins | 1 | 2004 | 87 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 2036 | 0.010 |
Why?
|
| Pain | 1 | 2006 | 416 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 230 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2004 | 115 | 0.010 |
Why?
|
| Hypothermia, Induced | 1 | 2004 | 95 | 0.010 |
Why?
|
| Heart Arrest, Induced | 1 | 2002 | 30 | 0.010 |
Why?
|
| Doxycycline | 1 | 2002 | 40 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2002 | 156 | 0.010 |
Why?
|
| Perfusion | 1 | 2004 | 271 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2002 | 96 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 889 | 0.010 |
Why?
|
| Hypercapnia | 1 | 2000 | 51 | 0.010 |
Why?
|
| Endothelium | 1 | 2000 | 63 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2000 | 158 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 1751 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2002 | 358 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2004 | 910 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2000 | 286 | 0.010 |
Why?
|
| Blood Circulation | 1 | 1999 | 29 | 0.010 |
Why?
|
| Swine | 1 | 2000 | 592 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 3021 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 882 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2000 | 2572 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 29427 | 0.010 |
Why?
|